Cogenic Limited - Period Ending 2020-03-31

Cogenic Limited - Period Ending 2020-03-31


Cogenic Limited 04178659 false 2019-04-01 2020-03-31 2020-03-31 The principal activity of the company is property investment Digita Accounts Production Advanced 6.26.9041.0 true 04178659 2019-04-01 2020-03-31 04178659 2020-03-31 04178659 bus:OrdinaryShareClass1 2020-03-31 04178659 core:CurrentFinancialInstruments 2020-03-31 04178659 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 04178659 core:Non-currentFinancialInstruments 2020-03-31 04178659 core:Non-currentFinancialInstruments core:AfterOneYear 2020-03-31 04178659 core:FurnitureFittingsToolsEquipment 2020-03-31 04178659 core:InvestmentPropertyIncludedWithinPPE 2020-03-31 04178659 core:LandBuildings 2020-03-31 04178659 core:OtherPropertyPlantEquipment 2020-03-31 04178659 bus:SmallEntities 2019-04-01 2020-03-31 04178659 bus:AuditExemptWithAccountantsReport 2019-04-01 2020-03-31 04178659 bus:FullAccounts 2019-04-01 2020-03-31 04178659 bus:SmallCompaniesRegimeForAccounts 2019-04-01 2020-03-31 04178659 bus:RegisteredOffice 2019-04-01 2020-03-31 04178659 bus:CompanySecretary1 2019-04-01 2020-03-31 04178659 bus:Director3 2019-04-01 2020-03-31 04178659 bus:OrdinaryShareClass1 2019-04-01 2020-03-31 04178659 bus:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31 04178659 core:FurnitureFittingsToolsEquipment 2019-04-01 2020-03-31 04178659 core:InvestmentPropertyIncludedWithinPPE 2019-04-01 2020-03-31 04178659 core:LandBuildings 2019-04-01 2020-03-31 04178659 core:OfficeEquipment 2019-04-01 2020-03-31 04178659 core:OtherPropertyPlantEquipment 2019-04-01 2020-03-31 04178659 core:PlantMachinery 2019-04-01 2020-03-31 04178659 countries:AllCountries 2019-04-01 2020-03-31 04178659 2019-03-31 04178659 core:FurnitureFittingsToolsEquipment 2019-03-31 04178659 core:LandBuildings 2019-03-31 04178659 core:OtherPropertyPlantEquipment 2019-03-31 04178659 2018-04-01 2019-03-31 04178659 2019-03-31 04178659 bus:OrdinaryShareClass1 2019-03-31 04178659 core:CurrentFinancialInstruments 2019-03-31 04178659 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 04178659 core:Non-currentFinancialInstruments 2019-03-31 04178659 core:Non-currentFinancialInstruments core:AfterOneYear 2019-03-31 04178659 core:FurnitureFittingsToolsEquipment 2019-03-31 04178659 core:InvestmentPropertyIncludedWithinPPE 2019-03-31 04178659 core:LandBuildings 2019-03-31 04178659 core:OtherPropertyPlantEquipment 2019-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04178659

Cogenic Limited



Annual Report and Unaudited Financial Statements for Statutory Filing

for the Year Ended 31 March 2020

 

Cogenic Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 9

 

Cogenic Limited

Company Information

Director

Mr K Parry

Company secretary

Mr J Gavin

Registered office

7 St James Business Park
Grimbald Crag Court
Knaresborough
North Yorkshire
HG5 8QB

Accountants

DJN Accountants
7 St James Business Park
Grimbald Crag Court
Knaresborough
North Yorkshire
HG5 8QB

 

Cogenic Limited

(Registration number: 04178659)
Balance Sheet as at 31 March 2020

Note

2020
£

2019
£

Fixed assets

 

Tangible assets

4

404,192

197,692

Current assets

 

Cash at bank and in hand

 

9,129

191,032

Creditors: Amounts falling due within one year

6

(266,595)

(236,530)

Net current liabilities

 

(257,466)

(45,498)

Total assets less current liabilities

 

146,726

152,194

Creditors: Amounts falling due after more than one year

6

(183,675)

(183,675)

Net liabilities

 

(36,949)

(31,481)

Capital and reserves

 

Called up share capital

7

2

2

Profit and loss account

(36,951)

(31,483)

Shareholders' deficit

 

(36,949)

(31,481)

For the financial year ending 31 March 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 18 November 2020
 

.........................................

Mr K Parry
Director

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
7 St James Business Park
Grimbald Crag Court
Knaresborough
North Yorkshire
HG5 8QB
England

These financial statements were authorised for issue by the director on 18 November 2020.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% reducing balance

Office Equipment

33% reducing balance

Investment property

Investment property is included at fair value. Gains are recognised in the income statement. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2019 - 1).

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2019

196,044

1,594

6,346

203,984

Additions

207,013

-

-

207,013

At 31 March 2020

403,057

1,594

6,346

410,997

Depreciation

At 1 April 2019

-

390

5,902

6,292

Charge for the year

-

402

111

513

At 31 March 2020

-

792

6,013

6,805

Carrying amount

At 31 March 2020

403,057

802

333

404,192

At 31 March 2019

196,044

1,204

444

197,692

Included within the net book value of land and buildings above is £403,057 (2019 - £196,044) in respect of freehold land and buildings.
 

Revaluation

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

The fair value of the company's investment properties included within land and buildings was revalued on 31 March 2020. An independent valuer was not involved.
The directors of the company have revalued the investment property on an open market value based on professional valuations and comparable properties.
Had this class of asset been measured on a historical cost basis, the carrying amount would have been £403,057 (2019 - £196,044).

5

Debtors

2020
£

2019
£

-

-

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

6

Creditors

Creditors: amounts falling due within one year

2020
£

2019
£

Due within one year

Taxation and social security

201

-

Accruals and deferred income

21,851

16,037

Other creditors

244,543

220,493

266,595

236,530

Creditors: amounts falling due after more than one year

Note

2020
£

2019
£

Due after one year

 

Loans and borrowings

8

183,675

183,675

7

Share capital

Allotted, called up and fully paid shares

 

2020

2019

 

No.

£

No.

£

Ordinay of £1 each

2

2

2

2

         

8

Loans and borrowings

2020
£

2019
£

Non-current loans and borrowings

Bank borrowings

183,675

183,675

9

Transition to FRS 102

Balance Sheet at 1 April 2018
 

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

As originally reported
£

Reclassification
£

Remeasurement
£

As restated
£

Capital and reserves

Total equity

-

-

-

-

 

Cogenic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Balance Sheet at 31 March 2019
 

As originally reported
£

Reclassification
£

Remeasurement
£

As restated
£

Capital and reserves

Total equity

-

-

-

-